3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasm Metastasis
30
Prostatic Neoplasms
18
Lung Neoplasms
17
Breast Neoplasms
17
Glioblastoma
16
Carcinoma, Non-Small-Cell Lung
16
Colorectal Neoplasms
14
Pancreatic Neoplasms
13
Multiple Myeloma
12
Glioma
12
Brain Neoplasms
11
Carcinoma, Renal Cell
10
Squamous Cell Carcinoma of Head and Neck
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, Follicular
9
Astrocytoma
9
Neoplasms
8
Melanoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Carcinoma, Hepatocellular
8
Triple Negative Breast Neoplasms
7
Ovarian Neoplasms
7
Lymphoma, Non-Hodgkin
7
Cholangiocarcinoma
7
Lymphoma, Mantle-Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma, B-Cell
6
Gliosarcoma
6
Central Nervous System Neoplasms
6
Carcinoma
6
Interventions
Magnetoencephalography
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Cerebral Primitive Tumor With Chirurgical Indication
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT02077504
2018-05-09
CONDUCTOME
University Hospital, Grenoble
Phase 1
Terminated
28 enrolled